Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of single doses of HC022 in healthy subjects, with systemic lupus erythematosus listed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• HC022 (HC022)

Snippet

Sponsor: HC Biopharma Inc. | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING